<DOC>
	<DOCNO>NCT00035503</DOCNO>
	<brief_summary>The purpose study see etiprednol dicloacetate safe effective treatment acute Crohn 's disease .</brief_summary>
	<brief_title>Multicenter Trial For Patients With Acute Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Must active confirm Crohn 's disease CDAI &gt; 220 &lt; 400 . Otherwise healthy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>